Epstein Secrets

es: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein an

ed, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval. ... It means that the agency recognizes that remdesivir is relatively safe to

es: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein and

ted, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval.... It means that the agency recognizes that remdesivir is relatively safe to

ves: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year. In addition, the bank will take back millions in past pay from Solomon's predecessor, Lloyd Blankfein an

ed, "Tonight, the FDA has now approved the first drug to treat COVID-19. Hospitalizations rising in 40 states, six now hitting record highs." ABC's Matt Gutman added that FDA's announcement is "basically the gold seal of approval. ... It means that the agency recognizes that remdesivir is relatively safe to